Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1925 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Catalent Signs Collaboration Agreement With Endotis

Using Catalent’s drug delivery technologies, the two companies will collaborate exclusively to develop certain oral formulations of small-glycol drugs. Oral formulations of synthetic oligosaccharides will allow full exploitation

Catalent Forges Strategic Alliance With Endotis

Catalent Pharma Solutions (Catalent) has entered into a strategic alliance with Endotis Pharma for the development of oral formulations of synthetic oligosaccharides. Using Catalent’s drug delivery technologies, the